Windtree Book Value Per Share vs Dividend Yield Analysis

WINT Stock

USD 0.10 0.02 16.67%

Windtree Therapeutics financial indicator trend analysis is more than just analyzing Windtree Therapeutics current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Windtree Therapeutics is a good investment. Please check the relationship between Windtree Therapeutics Book Value Per Share and its Dividend Yield accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Book Value Per Share vs Dividend Yield

Book Value Per Share vs Dividend Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Windtree Therapeutics Book Value Per Share account and Dividend Yield. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Windtree Therapeutics' Book Value Per Share and Dividend Yield is 0.1. Overlapping area represents the amount of variation of Book Value Per Share that can explain the historical movement of Dividend Yield in the same time period over historical financial statements of Windtree Therapeutics, assuming nothing else is changed. The correlation between historical values of Windtree Therapeutics' Book Value Per Share and Dividend Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value Per Share of Windtree Therapeutics are associated (or correlated) with its Dividend Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividend Yield has no effect on the direction of Book Value Per Share i.e., Windtree Therapeutics' Book Value Per Share and Dividend Yield go up and down completely randomly.

Correlation Coefficient

0.1

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Dividend Yield

Dividend Yield is Windtree Therapeutics dividend as a percentage of Windtree Therapeutics stock price. Windtree Therapeutics dividend yield is a measure of Windtree Therapeutics stock productivity, which can be interpreted as interest rate earned on an Windtree Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Most indicators from Windtree Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Windtree Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.At this time, Windtree Therapeutics' Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 75.65 in 2025, whereas Tax Provision is likely to drop (6.3 K) in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	53K	50K	235K	223.3K
Depreciation And Amortization	1.1M	82K	84K	79.8K

Interest Expense Depreciation And Amortization

Windtree Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Net	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Property Plant And Equipment Gross	Common Stock	Non Currrent Assets Other	Inventory	Other Liab	Current Deferred Revenue
Total Assets		0.51	0.02	0.25	0.96	-0.47	-0.29	0.19	0.44	0.72	-0.26	0.44	0.73	0.46	-0.25	0.33	0.4	0.84	0.47	-0.3	-0.01	-0.31	-0.17	-0.37	0.65	-0.15
Short Long Term Debt Total	0.51		0.35	0.39	0.32	-0.12	-0.22	0.39	0.09	0.76	-0.12	0.39	0.83	0.43	0.39	0.13	0.39	0.34	0.44	-0.35	-0.42	-0.37	0.47	-0.51	0.05	-0.16
Other Current Liab	0.02	0.35		0.84	-0.06	-0.23	0.2	0.46	-0.14	-0.09	-0.27	-0.11	0.24	0.46	0.46	-0.01	0.44	-0.23	0.47	-0.43	-0.39	-0.44	0.45	-0.19	-0.52	0.65
Total Current Liabilities	0.25	0.39	0.84		0.13	-0.05	0.0	0.75	0.0	0.1	-0.45	0.03	0.46	0.31	0.47	-0.19	0.23	0.09	0.33	-0.45	-0.37	-0.46	0.31	-0.32	-0.15	0.46
Total Stockholder Equity	0.96	0.32	-0.06	0.13		-0.59	-0.13	0.03	0.43	0.53	-0.13	0.3	0.52	0.49	-0.44	0.35	0.44	0.78	0.5	-0.14	0.0	-0.15	-0.29	-0.15	0.6	-0.15
Net Debt	-0.47	-0.12	-0.23	-0.05	-0.59		-0.18	0.2	0.02	-0.01	-0.09	0.04	-0.03	-0.9	0.56	-0.37	-0.92	0.02	-0.9	0.13	0.0	0.14	0.04	-0.04	0.13	-0.11
Retained Earnings	-0.29	-0.22	0.2	0.0	-0.13	-0.18		-0.2	-0.22	-0.61	0.75	-0.89	-0.54	0.2	-0.07	-0.39	0.19	-0.42	0.18	0.75	-0.65	0.74	0.12	0.89	-0.64	-0.06
Accounts Payable	0.19	0.39	0.46	0.75	0.03	0.2	-0.2		0.17	0.23	-0.41	0.2	0.49	0.07	0.42	-0.37	0.0	0.16	0.08	-0.36	-0.24	-0.36	0.44	-0.4	0.03	0.18
Common Stock Shares Outstanding	0.44	0.09	-0.14	0.0	0.43	0.02	-0.22	0.17		0.33	-0.14	0.21	0.29	-0.07	-0.1	0.11	-0.08	0.52	-0.07	-0.11	0.14	-0.1	-0.2	-0.19	0.46	-0.12
Non Current Liabilities Total	0.72	0.76	-0.09	0.1	0.53	-0.01	-0.61	0.23	0.33		-0.32	0.73	0.93	0.16	0.16	0.3	0.12	0.73	0.16	-0.44	0.09	-0.45	0.11	-0.68	0.61	-0.29
Other Current Assets	-0.26	-0.12	-0.27	-0.45	-0.13	-0.09	0.75	-0.41	-0.14	-0.32		-0.7	-0.45	0.1	-0.19	-0.38	0.11	-0.33	0.07	0.86	-0.42	0.85	0.23	0.79	-0.4	-0.46
Other Stockholder Equity	0.44	0.39	-0.11	0.03	0.3	0.04	-0.89	0.2	0.21	0.73	-0.7		0.66	-0.03	0.05	0.49	-0.03	0.55	-0.01	-0.72	0.58	-0.72	-0.07	-0.84	0.61	0.07
Total Liab	0.73	0.83	0.24	0.46	0.52	-0.03	-0.54	0.49	0.29	0.93	-0.45	0.66		0.26	0.32	0.2	0.2	0.68	0.27	-0.56	-0.06	-0.57	0.22	-0.72	0.48	-0.09
Total Current Assets	0.46	0.43	0.46	0.31	0.49	-0.9	0.2	0.07	-0.07	0.16	0.1	-0.03	0.26		-0.26	0.18	0.99	-0.07	1.0	-0.19	-0.23	-0.21	0.25	-0.08	-0.28	0.06
Short Term Debt	-0.25	0.39	0.46	0.47	-0.44	0.56	-0.07	0.42	-0.1	0.16	-0.19	0.05	0.32	-0.26		-0.32	-0.29	-0.11	-0.26	-0.13	-0.33	-0.13	0.28	-0.21	-0.22	0.05
Property Plant And Equipment Net	0.33	0.13	-0.01	-0.19	0.35	-0.37	-0.39	-0.37	0.11	0.3	-0.38	0.49	0.2	0.18	-0.32		0.23	0.29	0.19	-0.5	0.42	-0.51	-0.19	-0.38	0.25	0.34
Cash	0.4	0.39	0.44	0.23	0.44	-0.92	0.19	0.0	-0.08	0.12	0.11	-0.03	0.2	0.99	-0.29	0.23		-0.14	0.99	-0.21	-0.18	-0.22	0.26	-0.09	-0.32	0.09
Non Current Assets Total	0.84	0.34	-0.23	0.09	0.78	0.02	-0.42	0.16	0.52	0.73	-0.33	0.55	0.68	-0.07	-0.11	0.29	-0.14		-0.06	-0.21	0.11	-0.21	-0.32	-0.34	0.88	-0.2
Cash And Short Term Investments	0.47	0.44	0.47	0.33	0.5	-0.9	0.18	0.08	-0.07	0.16	0.07	-0.01	0.27	1.0	-0.26	0.19	0.99	-0.06		-0.22	-0.21	-0.24	0.24	-0.11	-0.27	0.08
Common Stock Total Equity	-0.3	-0.35	-0.43	-0.45	-0.14	0.13	0.75	-0.36	-0.11	-0.44	0.86	-0.72	-0.56	-0.19	-0.13	-0.5	-0.21	-0.21	-0.22		-0.37	1.0	-0.13	0.91	-0.23	-0.56
Property Plant And Equipment Gross	-0.01	-0.42	-0.39	-0.37	0.0	0.0	-0.65	-0.24	0.14	0.09	-0.42	0.58	-0.06	-0.23	-0.33	0.42	-0.18	0.11	-0.21	-0.37		-0.36	-0.33	-0.38	0.43	0.06
Common Stock	-0.31	-0.37	-0.44	-0.46	-0.15	0.14	0.74	-0.36	-0.1	-0.45	0.85	-0.72	-0.57	-0.21	-0.13	-0.51	-0.22	-0.21	-0.24	1.0	-0.36		-0.14	0.91	-0.22	-0.57
Non Currrent Assets Other	-0.17	0.47	0.45	0.31	-0.29	0.04	0.12	0.44	-0.2	0.11	0.23	-0.07	0.22	0.25	0.28	-0.19	0.26	-0.32	0.24	-0.13	-0.33	-0.14		-0.13	-0.47	0.2
Inventory	-0.37	-0.51	-0.19	-0.32	-0.15	-0.04	0.89	-0.4	-0.19	-0.68	0.79	-0.84	-0.72	-0.08	-0.21	-0.38	-0.09	-0.34	-0.11	0.91	-0.38	0.91	-0.13		-0.4	-0.22
Other Liab	0.65	0.05	-0.52	-0.15	0.6	0.13	-0.64	0.03	0.46	0.61	-0.4	0.61	0.48	-0.28	-0.22	0.25	-0.32	0.88	-0.27	-0.23	0.43	-0.22	-0.47	-0.4		-0.27
Current Deferred Revenue	-0.15	-0.16	0.65	0.46	-0.15	-0.11	-0.06	0.18	-0.12	-0.29	-0.46	0.07	-0.09	0.06	0.05	0.34	0.09	-0.2	0.08	-0.56	0.06	-0.57	0.2	-0.22	-0.27

Click cells to compare fundamentals

Windtree Therapeutics Account Relationship Matchups

Windtree Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	112.9M	74.8M	38.0M	32.4M	27.9M	41.9M
Short Long Term Debt Total	18.8M	17.9M	17.3M	1.8M	1.8M	1.7M
Other Current Liab	3.8M	3.4M	1.6M	2.5M	2.7M	2.9M
Total Current Liabilities	6.1M	4.9M	2.5M	4.0M	5.7M	8.3M
Total Stockholder Equity	69.6M	41.9M	10.0M	3.4M	10.0M	9.5M
Net Debt	(13.1M)	(19.5M)	(3.9M)	(2.5M)	43K	45.2K
Retained Earnings	(717.7M)	(785.3M)	(824.5M)	(844.8M)	(846.6M)	(804.3M)
Accounts Payable	1.2M	693K	249K	809K	1.9M	1.6M
Common Stock Shares Outstanding	347.87	550.22	700.0	4.3K	52.6K	55.2K
Liabilities And Stockholders Equity	112.9M	74.8M	38.0M	32.4M	27.9M	41.9M
Non Current Liabilities Total	37.2M	28.0M	25.5M	25.0M	12.2M	14.1M
Other Current Assets	1.2M	1.1M	1.2M	1.1M	795K	1.0M
Other Stockholder Equity	787.2M	827.2M	834.5M	848.2M	856.6M	436.3M
Total Liab	43.3M	32.9M	27.9M	29.0M	17.9M	21.5M
Total Current Assets	18.1M	23.5M	7.4M	5.4M	2.6M	2.4M
Short Term Debt	1.2M	822K	656K	669K	841K	799.0K
Property Plant And Equipment Net	1.8M	3.4M	2.1M	1.6M	1.2M	1.1M
Cash	16.9M	22.3M	6.2M	4.3M	1.8M	1.7M
Non Current Assets Total	94.8M	51.3M	30.6M	27.0M	25.3M	18.3M
Cash And Short Term Investments	16.9M	22.3M	6.2M	4.3M	1.8M	1.7M
Property Plant And Equipment Gross	1.8M	3.4M	2.1M	5.4M	5.0M	2.7M
Common Stock	41K	17K	28K	6K	305K	294.6K
Other Liab	15.7M	15.8M	19.6M	10.9M	12.6M	13.2M
Property Plant Equipment	802K	798K	1.8M	3.4M	3.1M	2.1M
Net Tangible Assets	52.4M	(17.8M)	(23.2M)	(5.9M)	(5.3M)	(5.0M)
Short Long Term Debt	352K	294K	252K	233K	661K	628.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC